EUGLYCAEMIC DIABETIC KETOACIDOSIS (DKA) IN A 21-YEAROLD PATIENT ON SGLT-2 INHIBITO
Keywords:
ketoacidosis, sglt-2 inhibitor, dietAbstract
INTRODUCTION
A 21-year-old lady with Type 2 Diabetes Mellitus for 2 years was on Empagliflozin, Linagliptin and Metformin for 10 months. She developed Euglycaemic Ketoacidosis after voluntarily going on a low carbohydrate diet for 3 days.
CASE
The patient was diagnosed to have Type 2 Diabetes Mellitus in 2016. She was well but not compliant with diet control. In Dec 2018, she was noted to have HbA1c of 9.3% and fasting Triglyceride was 13.06 mmol/L. For 3 days she decided to have a strict low calorie and low carbohydrate diet. She developed nausea and vomiting and was found to be in ketoacidosis. Euglycaemic Ketoacidosis was confirmed by blood glucose of 6.3 mmol/L; urine ketone positive 3+; blood ketone high; lactic acid normal; bicarbonate less than 10 mmol/L. She recovered after treatment with dextrose / insulin infusion.
CONCLUSION
More vigilance is required for patients on SGLT-2 inhibitors who may have to undergo fasting or periods of reduced food intake eg after surgery or procedures.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.